Biocon unit launches Entracept biosimilar in Australia, expands global footprint

Etanercept is a TNF (tumor necrosis factor) inhibitor used to treat several autoimmune conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, plaque psoriasis, and ankylosing spondylitis.

Leave a Reply

Your email address will not be published. Required fields are marked *